Odyssey Semiconductor (ODII) 10-Q 9 Nov 22 2022 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2022	Nov. 09, 2022
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2022
Current Fiscal Year End Date	--12-31
Entity File Number	333-234741
Entity Registrant Name	Odyssey Semiconductor Technologies, Inc.
Entity Central Index Key	0001781405
Entity Tax Identification Number	84-1766761
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	9 Brown Road
Entity Address, City or Town	Ithaca
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14850
City Area Code	607
Local Phone Number	882-2754
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Elected Not To Use the Extended Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		12,726,911

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Current Assets:
Cash	$ 901,264	$ 2,598,213
Accounts receivable	58,780	6,170
Deferred expenses	0	7,870
Prepaid expenses and other current assets	71,118	225,260
Total Current Assets	1,031,162	2,837,513
Restricted cash	103,229	103,201
Property and equipment, net	1,002,599	853,290
Operating ROU Asset	574,117	0
Total Assets	2,711,107	3,794,004
Current Liabilities:
Accounts payable and accrued expenses	327,289	147,947
Loan payable - short term	78,984	74,134
Bridge loan- related party	1,250,000	0
Lease liability - short term portion	183,300	0
Deferred revenue	11,000	10,000
Total Current Liabilities	1,850,573	232,081
Long-term lease liability	390,820	0
Loans payable - long term	288,936	345,459
Total liabilities	2,530,329	577,540
Commitments and contingencies	0	0
Stockholders’ Equity:
Preferred stock, $0.0001 par value, 5,000,000 shares authorized; 0 shares issued and outstanding as of September 30, 2022 and December 31, 2021	0	0
Common stock, $0.0001 par value, 45,000,000 shares authorized, 12,726,911 shares issued and outstanding as of September 30, 2022 and December 31, 2021	1,272	1,272
Additional paid-in capital	10,590,834	9,873,345
Accumulated deficit	(10,411,328)	(6,658,153)
Total Stockholders’ Equity	180,778	3,216,464
Total Liabilities and Stockholders’ Equity	$ 2,711,107	$ 3,794,004

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value per share	$ 0.0001	$ 0.0001
Common stock, shares authorized	45,000,000	45,000,000
Common stock, shares issued	12,726,911	12,726,911
Common stock, shares outstanding	12,726,911	12,726,911

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Revenues	$ 208,780	$ 174,952	$ 259,299	$ 693,074
Cost of Revenues	129,111	47,969	183,207	792,239
Gross Profit (Loss)	79,669	126,983	76,092	(99,165)
Operating Expenses:
Research and development	535,123	454,658	1,552,012	1,073,737
Fixed Asset deposit - Reserve	153,126	0	153,126	0
Selling, general, and administrative	653,308	403,441	2,089,082	1,658,944
Total Operating Expenses	1,341,557	858,099	3,794,220	2,732,681
Loss From Operations	(1,261,888)	(731,116)	(3,718,128)	(2,831,846)
Other Income (Expense):
Forgiveness of PPP loan and other income	3,520	25,013	5,544	238,719
Interest income (expense)	(33,107)	(4,560)	(40,591)	(14,407)
Net Loss	$ (1,291,475)	$ (710,663)	$ (3,753,175)	$ (2,607,534)
Net (Loss) Income Per Share:
Basic	$ (0.10)	$ (0.06)	$ (0.29)	$ (0.21)
Diluted	$ (0.10)	$ (0.06)	$ (0.29)	$ (0.21)
Weighted Average Number of Common Shares Outstanding:
Basic	12,726,911	12,726,911	12,726,911	12,320,979
Diluted	12,726,911	12,726,911	12,726,911	12,320,979

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDER'S EQUITY (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance - June 30, 2021 at Dec. 31, 2020	$ 1,143	$ 4,046,370	$ (3,516,400)	$ 531,113
Beginning balance, shares at Dec. 31, 2020	11,429,661
Stock based compensation		678,918		678,918
Exercise of stock options	$ 4	68,434		68,438
Exercise of stock options, shares	45,625
Sale of shares of common stock	$ 125	5,006,375		5,006,500
Sale of shares of common stock , shares	1,251,625
Costs of stock sale		(407,445)		(407,445)
Net loss three months ended 9/30/2021			(895,111)	(895,111)
Balance - September 30, 2021 at Mar. 31, 2021	$ 1,272	9,392,652	(4,411,511)	4,982,413
Ending balance, shares at Mar. 31, 2021	12,726,911
Balance - June 30, 2021 at Dec. 31, 2020	$ 1,143	4,046,370	(3,516,400)	531,113
Beginning balance, shares at Dec. 31, 2020	11,429,661
Balance - September 30, 2021 at Dec. 31, 2021	$ 1,272	9,873,345	(6,658,153)	3,216,464
Ending balance, shares at Dec. 31, 2021	12,726,911
Balance - June 30, 2021 at Mar. 31, 2021	$ 1,272	9,392,652	(4,411,511)	4,982,413
Beginning balance, shares at Mar. 31, 2021	12,726,911
Stock based compensation		223,155		223,155
Net loss three months ended 9/30/2021			(1,001,760)	(1,001,760)
Balance - September 30, 2021 at Jun. 30, 2021	$ 1,272	9,615,807	(5,413,271)	4,203,808
Ending balance, shares at Jun. 30, 2021	12,726,911
Stock based compensation		221,350		221,350
Net loss three months ended 9/30/2021			(710,663)	(710,663)
Balance - September 30, 2021 at Sep. 30, 2021	$ 1,272	9,837,157	(6,123,934)	3,714,495
Ending balance, shares at Sep. 30, 2021	12,726,911
Balance - June 30, 2021 at Dec. 31, 2021	$ 1,272	9,873,345	(6,658,153)	3,216,464
Beginning balance, shares at Dec. 31, 2021	12,726,911
Stock based compensation		51,049		51,049
Net loss three months ended 9/30/2021			(1,129,975)	(1,129,975)
Balance - September 30, 2021 at Mar. 31, 2022	$ 1,272	9,924,394	(7,788,128)	2,137,538
Ending balance, shares at Mar. 31, 2022	12,726,911
Stock based compensation		458,750		458,750
Net loss three months ended 9/30/2021			(1,331,725)	(1,331,725)
Balance - September 30, 2021 at Jun. 30, 2022	$ 1,272	10,383,144	(9,119,853)	1,264,563
Ending balance, shares at Jun. 30, 2022	12,726,911
Stock based compensation		207,690		207,690
Net loss three months ended 9/30/2021			(1,291,475)	(1,291,475)
Balance - September 30, 2021 at Sep. 30, 2022	$ 1,272	$ 10,590,834	$ (10,411,328)	$ 180,778
Ending balance, shares at Sep. 30, 2022	12,726,911

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows From Operating Activities:
Net loss	$ (3,753,175)	$ (2,607,534)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	717,489	1,123,423
Forgiveness of PPP loan indebtedness	0	(210,680)
Reserve fixed asset deposit	153,126	0
Depreciation and amortization	132,211	124,631
Changes in operating assets and liabilities:
Contract assets	0	62,273
Accounts receivable	(52,610)	(37,168)
Prepaid expenses and other current assets	1,016	(1,693)
Deferred expenses	7,870	180,143
Accounts payable and accrued expenses	179,342	(67,843)
Deferred revenue	1,000	(230,447)
Total Adjustments	1,139,444	942,639
Net Cash Used In Operating Activities	(2,613,731)	(1,664,895)
Cash Flows Used In Investing Activities:
Purchases of property and equipment	(281,517)	(32,505)
Net Cash Used In Investing Activities	(281,517)	(32,505)
Cash Flows From Financing Activities:
Proceeds from sale of common stock, net of costs	0	4,599,055
Proceed from bridge loan	1,250,000
Proceeds from government loans	0	193,625
Repayment of government loans	(51,673)	(26,956)
Proceeds from exercise of stock options	0	68,438
Net Cash Provided By Financing Activities	1,198,327	4,834,162
Net Increase (Decrease) In Cash and Restricted Cash	(1,696,921)	3,136,712
Cash and Restricted Cash - Beginning Of Period	2,701,414	375,855
Cash and Restricted Cash - End Of Period	1,004,493	3,512,617
Cash and Restricted Cash Consisted of the Following:
Cash	901,264	3,409,429
Restricted cash	103,229	103,188
Cash and Restricted Cash	1,004,493	3,512,617
Cash paid during the year for:
Interest	14,143	6,911
Non-cash investing and financing activities:
Operating Lease ROU Asset	$ 693,683	$ 0

Nature of Operations and Liquid

Nature of Operations and Liquidity	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Liquidity	Note 1 – Nature of Operations and Liquidity Organization and Operations Odyssey Semiconductor Technologies, Inc. (“Odyssey Technologies”) was incorporated on April 12, 2019 under the laws of the State of Delaware. Odyssey Technologies, through its wholly-owned subsidiary, Odyssey Semiconductor, Inc. (“Odyssey Semiconductor”) and Odyssey Semiconductor’s wholly owned subsidiary, JR2J, LLC (“JR2J”) (collectively, the “Company”), is a semiconductor device company developing high-voltage power switching components and systems based on proprietary Gallium Nitride (“GaN”) processing technology. COVID-19 The extent of the impact and effects of the ongoing outbreak of the coronavirus (COVID-19) on the operation and financial performance of our business will depend on future developments, including the duration and spread of the outbreak, related travel advisories and restrictions, the consequential potential of staff shortages, supply chain delays, and project development delays, all of which are highly uncertain and cannot be predicted. If demand for the Company’s services or the Company’s ability to service customers are impacted for an extended period, especially as it relates to major customers, our financial condition and results of operations may be materially adversely affected. Liquidity and Financial Condition As of September 30, 2022, the Company had a cash balance, working capital deficiency and accumulated deficit of approximately $ 900,000 820,000 10,400,000 3,800,000 The Company believes its current cash on hand will not be sufficient to meet its operating obligations and capital requirements for at least twelve months from the issuance of these financial statements. This raises substantial doubt about our ability to continue as a going concern. Therefore, the Company will need to raise further capital through the sale of additional equity or debt securities or other debt instruments to support its future operations. The Company has engaged with an investment bank to assist with the fund raise; however, there can no assurance that a financing can be completed on terms acceptable to the Company. The Company has also taken preliminary steps to file a registration statement on Form S-1 with the SEC for a proposed public offering and a listing application with Nasdaq, but there is no assurance that the offering and the listing application will be successful. On August 8, 2022, the Company received the proceeds from a one-year bridge loan of $ 1,250,000 The Company’s operating needs include the planned costs to operate its business, including amounts required to fund working capital and capital expenditures. The Company’s future capital requirements and the adequacy of its available funds will depend on many factors, including the Company’s ability to successfully commercialize its products and services, competing technological and market developments, and the need to enter into collaborations with other companies or acquire other companies or technologies to enhance or complement its product and service offerings. There is also no assurance that the amount of funds the Company might raise will enable the Company to complete its development initiatives or attain profitable operations. If the Company is unable to obtain additional financing on a timely basis, it may have to curtail its development, marketing and promotional activities, which would have a material adverse effect on the Company’s business, financial condition and results of operations, and ultimately, the Company could be forced to discontinue its operations and liquidate.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 2 - Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of September 30, 2022 and for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and related disclosures as of December 31, 2021 and for the year then ended which have been previously filed. Use of Estimates Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and the amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, stock-based compensation, the collectability of receivables, the recoverability and useful lives of long-lived assets, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents in the financial statements. As of September 30, 2022 and December 31, 2021, the Company had no Restricted Cash Restricted cash was comprised of cash held as a security deposit in connection with the Company’s operating lease. See Note 8 – Commitments and Contingencies - Operating Lease for additional details. Deferred Expenses Deferred expenses consist of labor, materials and other costs that are attributable to customer contracts that the Company has not completed its performance obligation under the contract and, as a result, has not recognized revenue. As of September 30, 2022 and December 31, 2021, deferred expenses were approximately $ 0 8,000 Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation using the straight-line method over their estimated useful lives, once the asset is placed in service. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures which extend the economic life are capitalized. Leasehold improvements are depreciated over the lesser of their estimated useful lives or the remaining term of their respective lease. When assets are retired or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized in the statement of operations for the respective period. The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. An impairment loss would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The estimated useful lives of property and equipment are as follows: Schedule of estimated useful lives of property and equipment Schedule of estimated useful lives of property and equipment Asset Useful lives (years) Computer and office equipment 5 Lab equipment 5 Leasehold improvements shorter of useful life or lease term Machinery 7 15 Furniture 7 Offering Costs Deferred offering costs, which primarily consist of direct, incremental professional fees incurred in connection with a debt or equity financing, are capitalized as non-current assets on the consolidated balance sheets. Once the financing closes, the Company reclassifies such costs as either discounts to notes payable or as a reduction of proceeds received from equity transactions so that such costs are recorded as a reduction of additional paid-in capital. If the completion of a contemplated financing was deemed to be no longer probable, the related deferred offering costs would be charged to general and administrative expense in the consolidated financial statements. Leases In February 2016, the Financial Accounting Standards Board (the “FASB”) established Accounting Standards Codification (“ASC”) Topic 842, “Leases”, by issuing Accounting Standards Update (“ASU”) No. 2016-02, which requires lessees to now recognize operating leases on the balance sheet and disclose key information about leasing arrangements. ASC Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements ● Short-term lease accounting policy election allowing lessees to not recognize ROU assets and liabilities for leases with a term of 12 months or less; ● The option to not separate lease and non-lease components in the Company’s lease contracts; and ● The package of practical expedients applied to all of its leases, including (i) not reassessing whether any expired or existing contracts are or contain leases, (ii) not reassessing the lease classification for any expired or existing leases, and (iii) not reassessing the capitalization of initial direct costs for any existing leases. Adoption of this standard resulted in the recognition of operating lease right-of-use assets and corresponding lease liabilities of approximately $ 694,000 Revenue Recognition The Company recognizes revenue under ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps: ● Step 1: ● Step 2: ● Step 3: ● Step 4: ● Step 5: A majority of the Company’s revenues are generated from contracts with customers that require it to design, develop, manufacture, test and integrate complex equipment and to provide engineering and technical services according to customer specifications. These contracts are often priced on a time and material type basis. Revenues on time and material type contracts are generally recognized in each period based on the amount billable to the customer which is based on direct labor hours expended multiplied by the contractual fixed rate per hour, plus the actual costs of materials and other direct non-labor costs. The timing of the Company’s revenue recognition may differ from the timing of payment by its customers. A receivable is recorded when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied. Contract assets are comprised of unbilled contract receivables related to revenues earned but not yet invoiced to customers. During the nine months ended September 30, 2022 and 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods. The Company generated revenue from government contracts that reimburse the Company for certain allowable costs for funded projects. Such projects were completed in 2021. For contracts with government agencies, when the Company has concluded that it is the principal in conducting the research and development expenses and where the funding arrangement is considered central to the Company’s ongoing operations, the Company classifies the recognized funding received as revenue. The Company has determined that revenue generated from government grants is outside the scope of ASC 606 and, as a result, the Company recognizes revenue upon incurring qualifying, reimbursable expenses. During the nine months ended September 30, 2022 and 2021, the Company recognized approximately $ 0 418,000 Research and Development Research and development expenses are charged to operations as incurred. Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. Option forfeitures are accounted for at the time of occurrence. The expected term used is the estimated period of time that warrants or options are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee options. For investor warrants and non-employee options, the expected term used is the contractual life of the instrument being valued. The Company uses its trading history to support its historical volatility calculations. Net (Loss) Income per share of Common Stock Basic net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of vested shares of common stock outstanding during the period. Diluted net income per share of common stock is computed by dividing net income by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. The following shares were excluded from the calculation of weighted average dilutive shares of common stock because their inclusion would have been anti-dilutive: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share As of September 30, 2022 2021 Warrants 245,696 245,696 Options 2,048,246 3,550,031 Total 2,293,942 3,795,727 Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse. The Company has recorded a full valuation allowance against its deferred tax assets for all periods, due to the uncertainty of future utilization. The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management has evaluated and concluded that there were no Critical Accounting Policies and Estimates Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and judgments on historical experience, current economic and industry conditions and on various other factors that are believed to be reasonable under the circumstances. This forms the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that full consideration has been given to all relevant circumstances that we may be subject to, and the consolidated financial statements accurately reflect our best estimate of the results of operations, financial position and cash flows for the periods presented. On an ongoing basis, we evaluate our estimates and judgments for all assets and liabilities, including those related to the fair value of stock options for determination of the stock-based compensation expense. The amount of stock based compensation has been a significant expense over the nine months ended September 30, 2022 and 2021. The assumptions that go into the Black-Scholes calculation are the major driver of the calculation of the fair value of the stock options at the date of grant. The major assumption of volatility is based upon historical data, and the majority of the other assumptions used in the Black Scholes computation is based upon the terms of the specific stock option grant. Revenues and cost of sales are important metrics in demonstrating the completion of projects and shipment of products to customers, and the profitability of such revenues. Accordingly, revenue recognition is a critical accounting policy. The timing of the Company’s revenue recognition may differ from the timing of payment by its customers. A receivable is recorded when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied. Contract assets are comprised of unbilled contract receivables related to revenues earned but not yet invoiced to customers. We review the status of each project at each period end and determine whether the earnings process is complete and the revenue and costs of sales should be recognized. Recently Issued Accounting Standards In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses”. This update requires immediate recognition of management’s estimates of current expected credit losses (“CECL”). Under the prior model, losses were recognized only as they were incurred. The new model is applicable to all financial instruments that are not accounted for at fair value through net income. The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies. Early adoption is permitted. The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.

Prepaid Expenses and Other Curr

Prepaid Expenses and Other Current Assets	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	Note 3 - Prepaid Expenses and Other Current Assets Prepaid expenses consisted of the following: Schedule of Prepaid expenses and other current assets September 30, 2022 December 31, 2021 Insurance $ 24,953 $ 30,666 Legal Fees — 16,180 Deposit for equipment purchase 46,165 25,288 Deposit for leased equipment purchase — 153,126 Total $ 71,118 $ 225,260 In December 2021, the Company made a deposit of $ 153,126

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 4 – Property and Equipment Property and equipment consisted of the following: Schedule of property and equipment September 30, 2022 December 31, 2021 Computer and office equipment $ 2,807 $ 2,807 Lab equipment 15,606 15,606 Furniture 43,705 43,705 Leasehold improvements 709,645 450,374 Machinery 649,888 627,640 Subtotal 1,421,651 1,140,132 Accumulated Depreciation (419,052 ) (286,842 ) Property and Equipment, net $ 1,002,599 $ 853,290 Depreciation and amortization expense related to property and equipment was approximately $ 132,000 124,000

Accounts Payable and Accrued Ex

Accounts Payable and Accrued Expenses	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses	Note 5 - Accounts Payable and Accrued Expenses Accounts payable and accrued expenses consisted of the following: Schedule of Accounts Payable and Accrued Expenses September 30, 2022 December 31, 2021 Accounts payable $ 59,526 $ 67,970 Accrued expenses 188,380 29,994 Credit cards payable 56,803 36,690 Accrued interest and other 22,580 13,293 Total $ 327,289 $ 147,947

Stockholders_ Equity

Stockholders’ Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Stockholders’ Equity	Note 6 – Stockholders’ Equity Authorized Capital The Company is authorized to issue 45,000,000 0.0001 5,000,000 0.0001 No Common Stock Transactions In March 2021, the Company sold 1,251,625 4.00 5,006,500 407,445 89,730 5 4.00 480,000

Equity Compensation Plan

Equity Compensation Plan	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Equity Compensation Plan	Note 7 – Equity Compensation Plan On June 18, 2019, the Board of Directors and a majority of the Company’s shareholders approved the 2019 Equity Compensation Plan (the “2019 Plan”). The 2019 Plan provides for the issuance of incentive stock options, non-statutory stock options, rights to purchase common stock, stock appreciation rights, restricted stock, restricted stock, performance shares and performance units to employees, directors and consultants of the Company and its affiliates. The 2019 Plan requires the exercise price of stock options to be not less than the fair value of the Company’s common stock on the date of grant, or 110% of fair value in the case of incentive options granted to a ten-percent stockholder. On March 11, 2020, the Company granted the following 10 1.50 965,850 321,950 The grant was reduced to 500,000 options, including 375,000 options and 125,000 options respectively under the two categories, due to limitations under the 2019 Plan. The terms of the 125,000 performance-based options were established in the quarter ended December 31, 2020. The terms of the performance-based options were met during the quarter ended March 31, 2021. From June 1 to June 22, 2021, the Company granted five and 10 ten-year options to purchase 388,246 2.90 3.93 On September 22, 2021, upon the resignation of our then Chief Executive Officer and Chairman, a total of 1,911,160 options that he previously received were forfeited as of such date. On such date, the Company also provided the acceleration 25,000 On December 30, 2021, the Company granted five and 10 445,000 1.77 On February 9, 2022, subject to the shareholders’ approval, the Board of Directors approved that the aggregate number of shares authorized for issuance as awards under the 2019 Plan shall be 4,600,000 5 On April 26, 2022, the Company granted to Mr. Davidson an option to purchase 650,000 shares of the Company’s common stock at $1.66 per share. The option will vest at the rate of 25% per year on the anniversary date from the first day of his employment starting from April 1, 2023. The option will be subject to acceleration in vesting in connection with the occurrence of a change of control event during the term of Mr. Davidson’s employment. The stock option activity from January 1, 2021 through September 30, 2022 is as follows: Schedule of stock option activity Shares Weighted-Average Exercise Weighted-Average Remaining Balance, December 31, 2020 3,257,410 $ 1.50 9.1 Options granted 833,246 2.67 6.7 Options exercised (45,625 ) 1.50 — Options expired (735,625 ) 1.50 — Options forfeited (1,911,160 ) 1.50 — Balance, December 31, 2021 1,398,246 2.20 6.3 Options granted 650,000 1.66 9.6 Balance, September 30, 2022 2,048,246 2.03 6.6 Vested options at September 30, 2022 669,395 $ 1.98 1.96 The following table summarizes the outstanding options at September 30, 2022 by exercise price. Schedule Of Outstanding Options Exercise price Outstanding options Exercisable options $ 1.66 650,000 0 $ 1.50 565,000 460,000 $ 1.77 445,000 75,833 $ 3.93 268,000 106,000 $ 2.90 70,246 17,562 $ 3.55 50,000 10,000 2,048,246 669,395 At September 30, 2022, the Company has 2,236,129 The Company has estimated the fair value of all stock option awards as of the date of grant by applying the Black-Scholes option-pricing model. In applying the Black-Scholes option pricing model, the Company used the following weighted average assumptions for issuances during the nine months ended September 30, 2022 and 2021: Schedule of Valuation Assumptions 2022 2021 Risk-free interest rate 2.77 % 1.10 % Expected term 7.0 7.5 Expected volatility 100.4 % 81 % Expected dividends 0 0 Grant date fair value of common stock $ 1.38/share $ 2.45 share During the nine months ended September 30, 2022, the Company recognized stock-based compensation expense related to stock options of approximately $ 717,000 283,000 416,000 18,000 1,123,000 1,023,000 69,000 31,000 As of September 30, 2022, there was unamortized stock-based compensation of approximately $ 1,690,000 3.0

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 8 - Commitments and Contingencies Litigations, Claims, and Assessments From time to time, the Company is involved in various disputes, claims, liens and litigation matters arising out of the normal course of business which could result in a material adverse effect on the Company’s combined financial position, results of operations or cash flows. Liabilities for loss contingencies arising from claims, assessments, litigation, fines and penalties and other sources are recorded when it is probable that a liability has been incurred and the amount of the assessment can be reasonably estimated. As of September 30, 2022 and September 30, 2021, the Company had no outstanding claims or litigation and had no liabilities recorded for loss contingencies. Operating Lease On August 21, 2019, the Company entered into a lease for a 10,000 square foot facility consisting of lab and office space. The lease requires monthly payments of $ 16,667 November 30, 2025 100,000 The assets and liabilities from operating leases are recognized at the lease commencement date based on the present value of remaining lease payments over the lease term using the Company’s incremental borrowing rates or implicit rates, when readily determinable. Short-term leases, which have an initial term of 12 months or less, are not recorded on the balance sheet. The Company’s operating leases do not provide an implicit rate that can readily be determined. Therefore, the Company uses a discount rate based on its estimated incremental commercial borrowing rate, The following table presents information about the amount and timing of liabilities arising from the Company’s operating and finance leases as of September 30, 2022 (in thousands): Finance Lease, Liability, Fiscal Year Maturity Maturity of Lease Liabilities Operating Lease Liabilities 2022 (remainder of year) $ 50,000 2023 200,000 2024 200,000 2025 183,337 Total undiscounted operating lease payments $ 633,337 Less: Imputed interest 59,217 Present value of operating lease liabilities $ 574,120 Short-term portion 183,300 Long term portion $ 390,820 Remaining lease term in years 3.17 Discount rate 6.50 % The Company incurred lease expense for its operating lease of approximately $ 184,000 170,000 The Right of Use Asset at September 30, 2022 of $ 574,117 Employment Agreement On April 18, 2022, Mark Davidson was appointed as Chief Executive Officer of the Company. In connection with Mr. Davidson’s appointment as Chief Executive Officer of the Company, the Company agreed to pay Mr. Davidson an annual cash compensation of $ 300,000 150,000

Concentrations

Concentrations	9 Months Ended
	Sep. 30, 2022
Risks and Uncertainties [Abstract]
Concentrations	Note 9 – Concentrations During the nine months ended September 30, 2022, revenues were generated primarily from two customers. At September 30, 2022, all deferred revenues are attributable to one customer contract. During the nine months ended September 30, 2021, approximately 60

Government Loans

Government Loans	9 Months Ended
	Sep. 30, 2022
Government Loans
Government Loans	Note 10 – Government Loans Paycheck Protection Program Loans On May 1, 2020, the Company received loan proceeds in the amount of approximately $ 211,000 On February 24, 2021, the Company received $ 193,625 1 3,300 Economic Injury Disaster Loan Advance On May 1, 2020, the Company received an advance in the amount of $ 10,000 138,900 678 3.75 30 Tomkins County Area Development Loan On May 27, 2020, the Company received loan proceeds in the amount of $ 50,000 2.5 1,443 E quipment Loans On August 20, 2020, the Company received a loan of $ 100,000 2.5 1,775 100,000 5 5.0 2,072 75,000 5 2.5 1,331 The loans are summarized as follows: Schedule of loans September 30, 2022 December 31, 2021 Principal outstanding $ 370,732 $ 423,089 Deferred loan costs, net of amortization (2,812 ) (3,496 ) Subtotal 367,920 419,593 Less current portion (78,984 ) (74,134 ) Total long term portion $ 288,936 $ 345,459 Interest expense on the above debt instruments was approximately $ 10,000 14,000

Revision of stock compensation

Revision of stock compensation expense	9 Months Ended
	Sep. 30, 2022
Compensation Related Costs [Abstract]
Revision of stock compensation expense	Note 11 – Revision of stock compensation expense During the second quarter of 2022, the Company identified certain adjustments required to correct balances within stock-based compensation, which is included in operating expenses in the accompanying consolidated statements of operations, related to employees, directors and consultants (see Note 7 – Equity Compensation Plan) recorded during the three-month periods from June 2021 to March 2022. The Company had incorrectly calculated the amortization of the stock-based compensation for the periods from June 2021 to March 2022. The error discovered resulted in an understatement of the stock-based compensation expense for the periods June 2021 to March 2022 summarized as follows: Schedule of stock based compensation As previously reported adjustment As if restated Three months ended 6/30/2021 Gross profit (loss) (74,264 ) (369 ) (74,633 ) Operating expenses 1,238,394 24,253 1,262,647 Operating loss (1,312,658 ) 24,622 (1,288,036 ) Net loss (1,315,083 ) (24,622 ) (1,339,705 ) Additional paid in capital 9,929,130 24,622 9,953,752 Accumulated Deficit (5,726,594 ) (24,622 ) (5,751,216 ) Six months ended 6/30/2021 Gross profit (loss) (226,148 ) (369 ) (226,517 ) Operating expenses 2,187,905 24,253 2,212,158 Operating loss (2,414,053 ) 24,622 (2,389,431 ) Net loss (2,210,194 ) (24,622 ) (2,234,816 ) Additional paid in capital 9,929,130 24,622 9,953,752 Accumulated Deficit (5,726,594 ) (24,622 ) (5,751,216 ) Three months ended 9/30/2021 Gross profit (loss) 126,983 (1,173 ) 125,810 Operating expenses 858,099 77,034 935,133 Operating loss (731,116 ) 78,207 (652,909 ) Net loss (710,663 ) (78,207 ) (788,870 ) Additional paid in capital 9,837,157 78,207 9,915,364 Accumulated Deficit (6,123,934 ) (78,207 ) (6,202,141 ) Nine months ended 9/30/2021 Gross profit (loss) (99,165 ) (1,542 ) (100,707 ) Operating expenses 2,732,681 101,287 2,833,968 Operating loss (2,831,846 ) 102,829 (2,729,017 ) Net loss (2,607,534 ) (102,829 ) (2,710,363 ) Additional paid in capital 9,837,157 102,829 9,939,986 Accumulated Deficit (6,123,934 ) (102,829 ) (6,226,763 ) Year ended 12/31/2021 Gross profit (loss) (83,257 ) (2,431 ) (85,688 ) Operating expenses 3,474,593 159,625 3,634,218 Operating loss (3,557,850 ) 162,056 (3,395,794 ) Net loss (3,141,753 ) (162,056 ) (3,303,809 ) Additional paid in capital 9,873,345 162,056 10,035,401 Accumulated Deficit (6,658,153 ) (162,056 ) (6,820,209 ) Three months ended 3/31/2022 Gross profit (loss) (1,061 ) (1,507 ) (2,568 ) Operating expenses 1,127,111 98,961 1,226,072 Operating loss (1,128,172 ) 100,468 (1,027,704 ) Net loss (1,129,975 ) (100,468 ) (1,230,443 ) Additional paid in capital 9,924,394 262,523 10,186,917 Accumulated Deficit (7,788,128 ) (262,523 ) (8,050,651 ) Based upon an analysis of Accounting Standards Codification 250 “accounting Changes and Error Corrections (ASC 250), U.S. Securities and Exchange Commission (“SEC”) Staff Accounting Bulletin (“SAB”) No. 99, “Materiality” and SAB No. 108, “Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements” (“SAB 108”), the Company determined this error was immaterial to the previously-issued condensed consolidated financial statements, and as such no restatement was necessary. Correcting prior-period financial statements for such immaterial misstatements does not require previously filed reports to be amended. Accordingly, the misstatement was corrected in the period ended June 30, 2022. For the nine months ended September 30, 2022, correction of this error increased our stock-based compensation expense, total operating expenses and net loss for periods through March 31, 2022 by $262,523. Loss per share increased in the nine months ended September 30, 2021 by $0.01.

Bridge Loan _ Related Party

Bridge Loan – Related Party	9 Months Ended
	Sep. 30, 2022
Bridge Loan Related Party
Bridge Loan – Related Party	Note 12 – Bridge Loan – Related Party On August 8, 2022, the Company issued a secured convertible promissory note in the amount of $ 1,250,000 The Promissory Note was issued as part of a private placement (the “Offering”) for sale up to $ 3,750,000 2022 The Promissory Note bears interest at a rate of ten percent ( 10 5 18,000 The Company has elected to record the bridge loan at fair value, which approximated the face value at September 30, 2022. Pursuant to the Registration Rights Agreement, the Company agreed to file a registration statement to register the resale of the shares of common stock issuable upon the conversion of the Promissory Note within 60 calendar days after the final closing of the Offering and cause the registration statement to be declared effective by the Securities and Exchange Commission within 90 calendar days after the filing of the registration statement. In addition, the Company agrees to keep such registration statement effective for a period of two (2) years after its effective date or for such shorter period ending on the date on which all securities registered thereunder have been sold.

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 13 - Subsequent Events The Company has evaluated events that have occurred after the balance sheet and through November 9, 2022. Based upon the evaluation, the Company did not identify any recognized or non-recognized subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) which are considered necessary for a fair presentation of the unaudited condensed consolidated financial statements of the Company as of September 30, 2022 and for the three and nine months ended September 30, 2022 and 2021. The results of operations for the three and nine months ended September 30, 2022 are not necessarily indicative of the operating results for the full year ending December 31, 2022 or any other period. These unaudited condensed consolidated financial statements should be read in conjunction with the audited financial statements and related disclosures as of December 31, 2021 and for the year then ended which have been previously filed.
Use of Estimates	Use of Estimates Preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and the amounts disclosed in the related notes to the financial statements. The Company’s significant estimates used in these financial statements include, but are not limited to, fair value calculations for equity securities, stock-based compensation, the collectability of receivables, the recoverability and useful lives of long-lived assets, and the valuation allowance related to the Company’s deferred tax assets. Certain of the Company’s estimates could be affected by external conditions, including those unique to the Company and general economic conditions. It is reasonably possible that these external factors could have an effect on the Company’s estimates and could cause actual results to differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents in the financial statements. As of September 30, 2022 and December 31, 2021, the Company had no
Restricted Cash	Restricted Cash Restricted cash was comprised of cash held as a security deposit in connection with the Company’s operating lease. See Note 8 – Commitments and Contingencies - Operating Lease for additional details.
Deferred Expenses	Deferred Expenses Deferred expenses consist of labor, materials and other costs that are attributable to customer contracts that the Company has not completed its performance obligation under the contract and, as a result, has not recognized revenue. As of September 30, 2022 and December 31, 2021, deferred expenses were approximately $ 0 8,000
Property and Equipment	Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation using the straight-line method over their estimated useful lives, once the asset is placed in service. Expenditures for maintenance and repairs, which do not extend the economic useful life of the related assets, are charged to operations as incurred, and expenditures which extend the economic life are capitalized. Leasehold improvements are depreciated over the lesser of their estimated useful lives or the remaining term of their respective lease. When assets are retired or otherwise disposed of, the costs and related accumulated depreciation or amortization are removed from the accounts and any gain or loss on disposal is recognized in the statement of operations for the respective period. The Company’s long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. An impairment loss would be recognized when estimated future cash flows expected to result from the use of the asset and its eventual disposition are less than its carrying amount. The estimated useful lives of property and equipment are as follows: Schedule of estimated useful lives of property and equipment Schedule of estimated useful lives of property and equipment Asset Useful lives (years) Computer and office equipment 5 Lab equipment 5 Leasehold improvements shorter of useful life or lease term Machinery 7 15 Furniture 7
Offering Costs	Offering Costs Deferred offering costs, which primarily consist of direct, incremental professional fees incurred in connection with a debt or equity financing, are capitalized as non-current assets on the consolidated balance sheets. Once the financing closes, the Company reclassifies such costs as either discounts to notes payable or as a reduction of proceeds received from equity transactions so that such costs are recorded as a reduction of additional paid-in capital. If the completion of a contemplated financing was deemed to be no longer probable, the related deferred offering costs would be charged to general and administrative expense in the consolidated financial statements.
Leases	Leases In February 2016, the Financial Accounting Standards Board (the “FASB”) established Accounting Standards Codification (“ASC”) Topic 842, “Leases”, by issuing Accounting Standards Update (“ASU”) No. 2016-02, which requires lessees to now recognize operating leases on the balance sheet and disclose key information about leasing arrangements. ASC Topic 842 was subsequently amended by ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements ● Short-term lease accounting policy election allowing lessees to not recognize ROU assets and liabilities for leases with a term of 12 months or less; ● The option to not separate lease and non-lease components in the Company’s lease contracts; and ● The package of practical expedients applied to all of its leases, including (i) not reassessing whether any expired or existing contracts are or contain leases, (ii) not reassessing the lease classification for any expired or existing leases, and (iii) not reassessing the capitalization of initial direct costs for any existing leases. Adoption of this standard resulted in the recognition of operating lease right-of-use assets and corresponding lease liabilities of approximately $ 694,000
Revenue Recognition	Revenue Recognition The Company recognizes revenue under ASC Topic 606, “Revenue from Contracts with Customers” (“ASC 606”). The Company determines revenue recognition through the following steps: ● Step 1: ● Step 2: ● Step 3: ● Step 4: ● Step 5: A majority of the Company’s revenues are generated from contracts with customers that require it to design, develop, manufacture, test and integrate complex equipment and to provide engineering and technical services according to customer specifications. These contracts are often priced on a time and material type basis. Revenues on time and material type contracts are generally recognized in each period based on the amount billable to the customer which is based on direct labor hours expended multiplied by the contractual fixed rate per hour, plus the actual costs of materials and other direct non-labor costs. The timing of the Company’s revenue recognition may differ from the timing of payment by its customers. A receivable is recorded when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied. Contract assets are comprised of unbilled contract receivables related to revenues earned but not yet invoiced to customers. During the nine months ended September 30, 2022 and 2021, there was no revenue recognized from performance obligations satisfied (or partially satisfied) in previous periods. The Company generated revenue from government contracts that reimburse the Company for certain allowable costs for funded projects. Such projects were completed in 2021. For contracts with government agencies, when the Company has concluded that it is the principal in conducting the research and development expenses and where the funding arrangement is considered central to the Company’s ongoing operations, the Company classifies the recognized funding received as revenue. The Company has determined that revenue generated from government grants is outside the scope of ASC 606 and, as a result, the Company recognizes revenue upon incurring qualifying, reimbursable expenses. During the nine months ended September 30, 2022 and 2021, the Company recognized approximately $ 0 418,000
Research and Development	Research and Development Research and development expenses are charged to operations as incurred.
Stock-Based Compensation	Stock-Based Compensation The Company measures the cost of services received in exchange for an award of equity instruments based on the fair value of the award. The fair value of the award is measured on the grant date. The fair value amount is then recognized over the period during which services are required to be provided in exchange for the award, usually the vesting period. Upon the exercise of an award, the Company issues new shares of common stock out of its authorized shares. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued. Option forfeitures are accounted for at the time of occurrence. The expected term used is the estimated period of time that warrants or options are expected to be outstanding. The Company utilizes the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee options. For investor warrants and non-employee options, the expected term used is the contractual life of the instrument being valued. The Company uses its trading history to support its historical volatility calculations.
Net (Loss) Income per share of Common Stock	Net (Loss) Income per share of Common Stock Basic net (loss) income per share of common stock is computed by dividing net (loss) income by the weighted average number of vested shares of common stock outstanding during the period. Diluted net income per share of common stock is computed by dividing net income by the weighted average number of common and dilutive common-equivalent shares outstanding during each period. The following shares were excluded from the calculation of weighted average dilutive shares of common stock because their inclusion would have been anti-dilutive: Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share As of September 30, 2022 2021 Warrants 245,696 245,696 Options 2,048,246 3,550,031 Total 2,293,942 3,795,727
Income Taxes	Income Taxes The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of items that have been included or excluded in the financial statements or tax returns. Deferred tax assets and liabilities are determined on the basis of the difference between the tax basis of assets and liabilities and their respective financial reporting amounts (“temporary differences”) at enacted tax rates in effect for the years in which the temporary differences are expected to reverse. The Company has recorded a full valuation allowance against its deferred tax assets for all periods, due to the uncertainty of future utilization. The Company utilizes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. Management has evaluated and concluded that there were no Critical Accounting Policies and Estimates Our consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base our estimates and judgments on historical experience, current economic and industry conditions and on various other factors that are believed to be reasonable under the circumstances. This forms the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe that full consideration has been given to all relevant circumstances that we may be subject to, and the consolidated financial statements accurately reflect our best estimate of the results of operations, financial position and cash flows for the periods presented. On an ongoing basis, we evaluate our estimates and judgments for all assets and liabilities, including those related to the fair value of stock options for determination of the stock-based compensation expense. The amount of stock based compensation has been a significant expense over the nine months ended September 30, 2022 and 2021. The assumptions that go into the Black-Scholes calculation are the major driver of the calculation of the fair value of the stock options at the date of grant. The major assumption of volatility is based upon historical data, and the majority of the other assumptions used in the Black Scholes computation is based upon the terms of the specific stock option grant. Revenues and cost of sales are important metrics in demonstrating the completion of projects and shipment of products to customers, and the profitability of such revenues. Accordingly, revenue recognition is a critical accounting policy. The timing of the Company’s revenue recognition may differ from the timing of payment by its customers. A receivable is recorded when revenue is recognized prior to payment and the Company has an unconditional right to payment. Alternatively, when payment precedes the provision of the related services, the Company records deferred revenue until the performance obligations are satisfied. Contract assets are comprised of unbilled contract receivables related to revenues earned but not yet invoiced to customers. We review the status of each project at each period end and determine whether the earnings process is complete and the revenue and costs of sales should be recognized.
Recently Issued Accounting Standards	Recently Issued Accounting Standards In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, “Financial Instruments - Credit Losses”. This update requires immediate recognition of management’s estimates of current expected credit losses (“CECL”). Under the prior model, losses were recognized only as they were incurred. The new model is applicable to all financial instruments that are not accounted for at fair value through net income. The standard is effective for fiscal years beginning after December 15, 2022 for public entities qualifying as small reporting companies. Early adoption is permitted. The Company is currently assessing the impact of this update on our consolidated financial statements and do not anticipate a significant impact.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Schedule of estimated useful lives of property and equipment	Schedule of estimated useful lives of property and equipment Schedule of estimated useful lives of property and equipment Asset Useful lives (years) Computer and office equipment 5 Lab equipment 5 Leasehold improvements shorter of useful life or lease term Machinery 7 15 Furniture 7
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share As of September 30, 2022 2021 Warrants 245,696 245,696 Options 2,048,246 3,550,031 Total 2,293,942 3,795,727

Prepaid Expenses and Other Cu_2

Prepaid Expenses and Other Current Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of Prepaid expenses and other current assets	Schedule of Prepaid expenses and other current assets September 30, 2022 December 31, 2021 Insurance $ 24,953 $ 30,666 Legal Fees — 16,180 Deposit for equipment purchase 46,165 25,288 Deposit for leased equipment purchase — 153,126 Total $ 71,118 $ 225,260

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Schedule of property and equipment September 30, 2022 December 31, 2021 Computer and office equipment $ 2,807 $ 2,807 Lab equipment 15,606 15,606 Furniture 43,705 43,705 Leasehold improvements 709,645 450,374 Machinery 649,888 627,640 Subtotal 1,421,651 1,140,132 Accumulated Depreciation (419,052 ) (286,842 ) Property and Equipment, net $ 1,002,599 $ 853,290

Accounts Payable and Accrued _2

Accounts Payable and Accrued Expenses (Tables)	9 Months Ended
	Sep. 30, 2022
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Expenses	Schedule of Accounts Payable and Accrued Expenses September 30, 2022 December 31, 2021 Accounts payable $ 59,526 $ 67,970 Accrued expenses 188,380 29,994 Credit cards payable 56,803 36,690 Accrued interest and other 22,580 13,293 Total $ 327,289 $ 147,947

Equity Compensation Plan (Table

Equity Compensation Plan (Tables)	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Schedule of stock option activity	Schedule of stock option activity Shares Weighted-Average Exercise Weighted-Average Remaining Balance, December 31, 2020 3,257,410 $ 1.50 9.1 Options granted 833,246 2.67 6.7 Options exercised (45,625 ) 1.50 — Options expired (735,625 ) 1.50 — Options forfeited (1,911,160 ) 1.50 — Balance, December 31, 2021 1,398,246 2.20 6.3 Options granted 650,000 1.66 9.6 Balance, September 30, 2022 2,048,246 2.03 6.6 Vested options at September 30, 2022 669,395 $ 1.98 1.96
Schedule Of Outstanding Options	Schedule Of Outstanding Options Exercise price Outstanding options Exercisable options $ 1.66 650,000 0 $ 1.50 565,000 460,000 $ 1.77 445,000 75,833 $ 3.93 268,000 106,000 $ 2.90 70,246 17,562 $ 3.55 50,000 10,000 2,048,246 669,395
Schedule of Valuation Assumptions	Schedule of Valuation Assumptions 2022 2021 Risk-free interest rate 2.77 % 1.10 % Expected term 7.0 7.5 Expected volatility 100.4 % 81 % Expected dividends 0 0 Grant date fair value of common stock $ 1.38/share $ 2.45 share

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Finance Lease, Liability, Fiscal Year Maturity	Finance Lease, Liability, Fiscal Year Maturity Maturity of Lease Liabilities Operating Lease Liabilities 2022 (remainder of year) $ 50,000 2023 200,000 2024 200,000 2025 183,337 Total undiscounted operating lease payments $ 633,337 Less: Imputed interest 59,217 Present value of operating lease liabilities $ 574,120 Short-term portion 183,300 Long term portion $ 390,820 Remaining lease term in years 3.17 Discount rate 6.50 %

Government Loans (Tables)

Government Loans (Tables)	9 Months Ended
	Sep. 30, 2022
Government Loans
Schedule of loans	Schedule of loans September 30, 2022 December 31, 2021 Principal outstanding $ 370,732 $ 423,089 Deferred loan costs, net of amortization (2,812 ) (3,496 ) Subtotal 367,920 419,593 Less current portion (78,984 ) (74,134 ) Total long term portion $ 288,936 $ 345,459

Revision of stock compensatio_2

Revision of stock compensation expense (Tables)	9 Months Ended
	Sep. 30, 2022
Compensation Related Costs [Abstract]
Schedule of stock based compensation	Schedule of stock based compensation As previously reported adjustment As if restated Three months ended 6/30/2021 Gross profit (loss) (74,264 ) (369 ) (74,633 ) Operating expenses 1,238,394 24,253 1,262,647 Operating loss (1,312,658 ) 24,622 (1,288,036 ) Net loss (1,315,083 ) (24,622 ) (1,339,705 ) Additional paid in capital 9,929,130 24,622 9,953,752 Accumulated Deficit (5,726,594 ) (24,622 ) (5,751,216 ) Six months ended 6/30/2021 Gross profit (loss) (226,148 ) (369 ) (226,517 ) Operating expenses 2,187,905 24,253 2,212,158 Operating loss (2,414,053 ) 24,622 (2,389,431 ) Net loss (2,210,194 ) (24,622 ) (2,234,816 ) Additional paid in capital 9,929,130 24,622 9,953,752 Accumulated Deficit (5,726,594 ) (24,622 ) (5,751,216 ) Three months ended 9/30/2021 Gross profit (loss) 126,983 (1,173 ) 125,810 Operating expenses 858,099 77,034 935,133 Operating loss (731,116 ) 78,207 (652,909 ) Net loss (710,663 ) (78,207 ) (788,870 ) Additional paid in capital 9,837,157 78,207 9,915,364 Accumulated Deficit (6,123,934 ) (78,207 ) (6,202,141 ) Nine months ended 9/30/2021 Gross profit (loss) (99,165 ) (1,542 ) (100,707 ) Operating expenses 2,732,681 101,287 2,833,968 Operating loss (2,831,846 ) 102,829 (2,729,017 ) Net loss (2,607,534 ) (102,829 ) (2,710,363 ) Additional paid in capital 9,837,157 102,829 9,939,986 Accumulated Deficit (6,123,934 ) (102,829 ) (6,226,763 ) Year ended 12/31/2021 Gross profit (loss) (83,257 ) (2,431 ) (85,688 ) Operating expenses 3,474,593 159,625 3,634,218 Operating loss (3,557,850 ) 162,056 (3,395,794 ) Net loss (3,141,753 ) (162,056 ) (3,303,809 ) Additional paid in capital 9,873,345 162,056 10,035,401 Accumulated Deficit (6,658,153 ) (162,056 ) (6,820,209 ) Three months ended 3/31/2022 Gross profit (loss) (1,061 ) (1,507 ) (2,568 ) Operating expenses 1,127,111 98,961 1,226,072 Operating loss (1,128,172 ) 100,468 (1,027,704 ) Net loss (1,129,975 ) (100,468 ) (1,230,443 ) Additional paid in capital 9,924,394 262,523 10,186,917 Accumulated Deficit (7,788,128 ) (262,523 ) (8,050,651 )

Nature of Operations and Liqu_2

Nature of Operations and Liquidity (Details Narrative) - USD ($)		9 Months Ended
	Aug. 08, 2022	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash and Cash Equivalents, at Carrying Value		$ 900,000
Working capital		820,000
Retained Earnings, Appropriated		10,400,000
Net Income (Loss) Available to Common Stockholders, Basic		$ 3,800,000
Proceed from bridge loan	$ 1,250,000

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details)	9 Months Ended
	Sep. 30, 2022
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	5 years
Lab Equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	5 years
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	shorter of useful life or lease term
Machinery [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	7 years
Machinery [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	15 years
Furniture [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, estimated useful lives	7 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Details 1) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive shares	2,293,942	3,795,727
Warrant [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive shares	245,696	245,696
Options Held [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total potentially dilutive shares	2,048,246	3,550,031

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jan. 02, 2022
Accounting Policies [Abstract]
Cash equivalents	$ 0		$ 0
Deferred expenses	0		8,000
operating lease right-of-use assets	574,117		0	$ 694,000
Grant revenue	0	$ 418,000
Uncertain tax positions	$ 0		$ 0

Prepaid Expenses and Other Cu_3

Prepaid Expenses and Other Current Assets (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Insurance	$ 24,953	$ 30,666
Legal Fees	0	16,180
Deposit for equipment purchase	46,165	25,288
Deposit for leased equipment purchase	0	153,126
Total	$ 71,118	$ 225,260

Prepaid Expenses and Other Cu_4

Prepaid Expenses and Other Current Assets (Details Narrative) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Deposits on Flight Equipment	$ 0	$ 153,126

Property and Equipment (Details

Property and Equipment (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,421,651	$ 1,140,132
Accumulated Depreciation	(419,052)	(286,842)
Property and equipment, net	1,002,599	853,290
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	2,807	2,807
Lab Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	15,606	15,606
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	43,705	43,705
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	709,645	450,374
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 649,888	$ 627,640

Property and Equipment (Detai_2

Property and Equipment (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]
Depreciation and amortization expense	$ 132,211	$ 124,631
Property, Plant and Equipment [Member]
Impaired Assets to be Disposed of by Method Other than Sale [Line Items]
Depreciation and amortization expense	$ 132,000	$ 124,000

Accounts Payable and Accrued _3

Accounts Payable and Accrued Expenses (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Payables and Accruals [Abstract]
Accounts payable	$ 59,526	$ 67,970
Accrued expenses	188,380	29,994
Credit cards payable	56,803	36,690
Accrued interest and other	22,580	13,293
Total	$ 327,289	$ 147,947

Stockholders_ Equity (Details N

Stockholders’ Equity (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]
Common stock, shares authorized		45,000,000		45,000,000
Common stock, par value per share		$ 0.0001		$ 0.0001
Preferred stock, shares authorized		5,000,000		5,000,000
Preferred stock, par value per share		$ 0.0001		$ 0.0001
Preferred stock, shares issued		0		0
Proceeds from stock of sold		$ 0	$ 4,599,055
Common Stock [Member] | Private Placement [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Number of stock sold	1,251,625
Share price	$ 4
Proceeds from stock of sold	$ 5,006,500
Proceeds from warrant exercised	$ 407,445
Number of warrant purchased	89,730
Warrant term	5 years
Exercise Price	$ 4
Proceeds from related parties	$ 480,000

Equity Compensation Plan (Detai

Equity Compensation Plan (Details) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options Outstanding, Ending	2,048,246
Equity Option [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Options Outstanding, beginning	1,398,246	3,257,410
Options Outstanding, beginning	$ 2.20	$ 1.50
Options Outstanding	6 years 7 months 6 days	6 years 3 months 18 days	9 years 1 month 6 days
Options Granted	650,000	833,246
Options Granted	$ 1.66	$ 2.67
Options granted	9 years 7 months 6 days	6 years 8 months 12 days
Options Exercised		(45,625)
Options Exercised		$ 1.50
Options expired		(735,625)
Options forfeited or expired		$ 1.50
Options forfeited or expired		(1,911,160)
Options forfeited or expired		$ 1.50
Options Outstanding, Ending	2,048,246	1,398,246	3,257,410
Options Outstanding, Ending	$ 2.03	$ 2.20	$ 1.50
Vested options at period end	669,395
Vested options, at period end	$ 1.98
Options vested	1 year 11 months 15 days

Equity Compensation Plan (Det_2

Equity Compensation Plan (Details 1)	Sep. 30, 2022 shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	2,048,246
Options Exercisable	669,395
$1.66 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	650,000
Options Exercisable	0
$1.50 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	565,000
Options Exercisable	460,000
$1.77 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	445,000
Options Exercisable	75,833
$3.93 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	268,000
Options Exercisable	106,000
$2.90 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	70,246
Options Exercisable	17,562
$3.55 [Member]
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]
Options Outstanding	50,000
Options Exercisable	10,000

Equity Compensation Plan (Det_3

Equity Compensation Plan (Details 2) - $ / shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Equity [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate	2.77%	1.10%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term	7 years	7 years 6 months
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate	100.40%	81%
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate	0%	0%
Grant date fair value of common stock	$ 1.38	$ 2.45

Equity Compensation Plan (Det_4

Equity Compensation Plan (Details Narrative) - USD ($)			1 Months Ended		9 Months Ended
	Feb. 09, 2022	Mar. 11, 2020	Dec. 30, 2021	Jun. 22, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 25, 2021	Sep. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding shares of common stock	5%
Stock-based compensation expense					$ 717,000	$ 1,123,000
Unamortized stock-based compensation					$ 1,690,000
Unamortized stock-based compensation period					3 years
Research and Development Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense					$ 283,000	69,000
General and Administrative Expense [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense					416,000	1,023,000
Cost of Sales [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense					$ 18,000	$ 31,000
N 2019 Equity Compensation Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of Shares Authorized	4,600,000
Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number							25,000	1,911,160
Options Held [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option grant term			10 years
Option exercise price			$ 1.77
Option granted			445,000	388,246
Equity Compensation Plan description		The grant was reduced to 500,000 options, including 375,000 options and 125,000 options respectively under the two categories, due to limitations under the 2019 Plan. The terms of the 125,000 performance-based options were established in the quarter ended December 31, 2020. The terms of the performance-based options were met during the quarter ended March 31, 2021.
Number of shares available for grant					2,236,129
Options Held [Member] | Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option exercise price				$ 2.90
Options Held [Member] | Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option exercise price				$ 3.93
Options Held [Member] | Executive Chairman [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option grant term		10 years
Option exercise price		$ 1.50
Option granted		965,850
Options Held [Member] | Chief Executive Officer [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Option granted		321,950

Commitments and Contingencies_2

Commitments and Contingencies (Details)	Sep. 30, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2022 (remainder of year)	$ 50,000
2023	200,000
2024	200,000
2025	183,337
Total undiscounted operating lease payments	633,337
Less: Imputed interest	59,217
Present value of operating lease liabilities	574,120
Short-term portion	183,300
Long term portion	$ 390,820
Weighted average remaining lease term in years	3 years 2 months 1 day
Weighted average discount rate	6.50%

Commitments and Contingencies_3

Commitments and Contingencies (Details Narrative) - USD ($)	1 Months Ended	9 Months Ended
	Apr. 18, 2022	Sep. 30, 2022	Sep. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
Monthly payments		$ 16,667
Lease expiration date		Nov. 30, 2025
Letter of credit		$ 100,000
Operating lease expense		184,000	$ 170,000
Right of Use Asset		$ 574,117
Annual cash compensation	$ 300,000
Bonus	$ 150,000

Concentrations (Details Narrati

Concentrations (Details Narrative)	9 Months Ended
	Sep. 30, 2021
Revenue Benchmark [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	60%

Government Loans (Details)

Government Loans (Details) - USD ($)	Sep. 30, 2022	Dec. 31, 2021
Government Loans
Principal outstanding	$ 370,732	$ 423,089
Deferred loan costs, net of amortization	(2,812)	(3,496)
Subtotal	367,920	419,593
Less current portion	(78,984)	(74,134)
Total long term portion	$ 288,936	$ 345,459

Government Loans (Details Narra

Government Loans (Details Narrative) - USD ($)			1 Months Ended					9 Months Ended
	Sep. 10, 2020	May 01, 2020	Feb. 24, 2021	Sep. 02, 2020	Aug. 30, 2020	Aug. 20, 2020	May 27, 2020	Sep. 30, 2022	Sep. 30, 2021
Debt Instrument [Line Items]
Proceeds from loan								$ 0	$ 193,625
Interest expense								$ 10,000	$ 14,000
Small Business Administration [Member]
Debt Instrument [Line Items]
Proceeds from loan		$ 10,000			$ 138,900
Interest rate					3.75%
Periodic payments					$ 678
Loan term					30 years
Tomkins County Area Development [Member]
Debt Instrument [Line Items]
Proceeds from loan	$ 75,000						$ 50,000
Interest rate	2.50%						2.50%
Periodic payments	$ 1,331						$ 1,443
Loan term	5 years
Paycheck Protection Program [Member]
Debt Instrument [Line Items]
Proceeds from loan		$ 211,000
Paycheck Protection Program 2 [Member]
Debt Instrument [Line Items]
Proceeds from loan			$ 193,625
Interest rate			1%
Periodic payments			$ 3,300
Equipment Loans [Member]
Debt Instrument [Line Items]
Proceeds from loan						$ 100,000
Interest rate						2.50%
Periodic payments						$ 1,775
Southern Tier Region Economic Development Corporation [Member]
Debt Instrument [Line Items]
Proceeds from loan				$ 100,000
Interest rate				5%
Periodic payments				$ 2,072
Loan term				5 years

Revision of stock compensatio_3

Revision of stock compensation expense (Details) - USD ($)	3 Months Ended				6 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Jun. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Gross profit (loss)	$ 79,669		$ 126,983			$ 76,092	$ (99,165)
Operating expenses	1,341,557		858,099			3,794,220	2,732,681
Operating loss	(1,261,888)		(731,116)			(3,718,128)	(2,831,846)
Net loss	(1,291,475)		(710,663)			(3,753,175)	(2,607,534)
Additional paid in capital	10,590,834					10,590,834		$ 9,873,345
Accumulated Deficit	$ (10,411,328)					$ (10,411,328)		(6,658,153)
Previously Reported [Member]
Gross profit (loss)		$ (1,061)	126,983	$ (74,264)	$ (226,148)		(99,165)	(83,257)
Operating expenses		1,127,111	858,099	1,238,394	2,187,905		2,732,681	3,474,593
Operating loss		(1,128,172)	(731,116)	(1,312,658)	(2,414,053)		(2,831,846)	(3,557,850)
Net loss		(1,129,975)	(710,663)	(1,315,083)	(2,210,194)		(2,607,534)	(3,141,753)
Additional paid in capital		9,924,394	9,837,157	9,929,130	9,929,130		9,837,157	9,873,345
Accumulated Deficit		(7,788,128)	(6,123,934)	(5,726,594)	(5,726,594)		(6,123,934)	(6,658,153)
Revision of Prior Period, Adjustment [Member]
Gross profit (loss)		(1,507)	(1,173)	(369)	(369)		(1,542)	(2,431)
Operating expenses		98,961	77,034	24,253	24,253		101,287	159,625
Operating loss		100,468	78,207	24,622	24,622		102,829	162,056
Net loss		(100,468)	(78,207)	(24,622)	(24,622)		(102,829)	(162,056)
Additional paid in capital		262,523	102,829	24,622	24,622		102,829	162,056
Accumulated Deficit		(262,523)	(102,829)	(24,622)	(24,622)		(102,829)	(162,056)
As Restated [Member]
Gross profit (loss)		(2,568)	125,810	(74,633)	(226,517)		(100,707)	(85,688)
Operating expenses		1,226,072	935,133	1,262,647	2,212,158		2,833,968	3,634,218
Operating loss		(1,027,704)	(652,909)	(1,288,036)	(2,389,431)		(2,729,017)	(3,395,794)
Net loss		(1,230,443)	(788,870)	(1,339,705)	(2,234,816)		(2,710,363)	(3,303,809)
Additional paid in capital		10,186,917	9,939,986	9,953,752	9,953,752		9,939,986	10,035,401
Accumulated Deficit		$ (8,050,651)	$ (6,226,763)	$ (5,751,216)	$ (5,751,216)		$ (6,226,763)	$ (6,820,209)

Revision of stock compensatio_4

Revision of stock compensation expense (Details Narrative)	9 Months Ended
	Sep. 30, 2022
Compensation Related Costs [Abstract]
Stock based compensation description	For the nine months ended September 30, 2022, correction of this error increased our stock-based compensation expense, total operating expenses and net loss for periods through March 31, 2022 by $262,523. Loss per share increased in the nine months ended September 30, 2021 by $0.01.

Bridge Loan _ Related Party (De

Bridge Loan – Related Party (Details Narrative) - USD ($)			3 Months Ended	9 Months Ended
	Aug. 15, 2022	Aug. 08, 2022	Sep. 30, 2022	Sep. 30, 2022
Debt Instrument [Line Items]
Proceed from issuance of debt		$ 1,250,000
Proceeds from Issuance of Private Placement	$ 3,750,000
Proceeds from issuance of common stock				$ 5,000
Interest expense			$ 18,000	$ 18,000
Promissory Note [Member]
Debt Instrument [Line Items]
Proceed from issuance of debt		$ 1,250,000
Interest rate				10%